Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting

BackgroundIn obstructive hypertrophic cardiomyopathy (HOCM), disopyramide is used in patients who remain symptomatic despite β-blockers or verapamil. However, effectiveness of disopyramide therapy has not been clearly established due to inconsistent definition of responders and the insufficient leng...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gaetano Todde, Lorenzo Lupo Dei, Roberto Polizzi, Domenico Gabrielli, Grazia Canciello, Silvio Romano, Felice Borrelli, Geza Halasz, Leopoldo Ordine, Salvatore Di Napoli, Daniela Pacella, Raffaella Lombardi, Giovanni Esposito, Federica Re, Maria-Angela Losi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-08-01
Edice:	Frontiers in Cardiovascular Medicine
Témata:	hypertrophic cardiomyopathy disopyramide obstruction therapy symptoms
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1416600/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!